Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹10Cr
Rev Gr TTM
Revenue Growth TTM
-20.37%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

DHYAANITR
VS
| Quarter | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | -44.5 | -100.0 | 81.7 | | 3.0 | -92.3 | 107.1 |
| 10 | 11 | 6 | 0 | 10 | 18 | 11 | 1 | 22 |
Operating Profit Operating ProfitCr |
| 3.0 | -8.3 | 1.6 | | 2.8 | 4.0 | 2.7 | 13.6 | 1.3 |
Other Income Other IncomeCr | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | | | -70.8 | -107.5 | 214.3 | 1,275.0 | 4.5 | -95.7 | -13.0 |
| 2.3 | 5.4 | 1.2 | | 2.1 | 2.5 | 2.1 | 1.4 | 0.9 |
| 0.0 | 0.0 | 0.2 | -0.1 | 0.5 | 1.1 | 0.1 | 0.0 | 0.1 |
| Financial Year | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | | -100.0 | | -23.8 | 104.5 | 39.0 | -54.5 | 221.6 | -58.6 | 94.4 |
| 0 | 0 | 0 | 9 | 7 | 15 | 21 | 9 | 28 | 12 | 23 |
Operating Profit Operating ProfitCr |
| | -0.5 | | 1.4 | -1.3 | -1.1 | -2.5 | -2.9 | 4.1 | 3.9 | 2.0 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| | | -74.2 | 12,781.9 | -174.3 | 519.2 | 153.1 | -110.0 | 990.3 | -63.9 | -11.3 |
| | -0.5 | | 1.0 | -1.0 | 2.1 | 3.8 | -0.8 | 2.3 | 2.0 | 0.9 |
| -1.5 | -0.1 | -0.1 | 19.5 | -14.5 | 60.8 | 7.4 | -0.2 | 1.6 | 0.1 | 0.2 |
| Financial Year | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Equity Capital Equity CapitalCr | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 4 | 17 |
| 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 1 | 18 |
Current Liabilities Current LiabilitiesCr | 0 | 0 | 0 | 10 | 14 | 6 | 13 | 21 | 30 | 20 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 5 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 0 | 0 | 0 | 10 | 14 | 6 | 15 | 23 | 31 | 51 |
Non Current Assets Non Current AssetsCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 7 | 9 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | 0 | 1 | 1 | 0 | -4 | -31 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing Cash Flow Financing Cash FlowCr | 0 | 0 | -1 | 1 | 0 | 3 | 31 |
|
Free Cash Flow Free Cash FlowCr | 0 | 0 | 1 | 1 | 0 | -4 | -31 |
| -414.6 | 539.2 | 250.3 | 147.3 | 257.3 | -645.0 | -12,646.1 |
CFO To EBITDA CFO To EBITDA% | -300.7 | 412.3 | -462.5 | -222.4 | 75.5 | -365.3 | -6,485.1 |
| Financial Year | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | | 0 | 0 | 0 | 0 | 0 | 0 | 22 | 8 | 17 |
Price To Earnings Price To Earnings | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 11.6 | 67.3 |
Price To Sales Price To Sales | | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 2.4 | 0.3 | 1.4 |
Price To Book Price To Book | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.2 | 1.6 | 0.5 |
| | 12.5 | 3.5 | 3.0 | -8.4 | 0.0 | 3.2 | -77.8 | 8.9 | 46.6 |
Profitability Ratios Profitability Ratios |
| | 3.5 | | 1.9 | -0.8 | 0.5 | 0.5 | 6.0 | 6.5 | 65.9 |
| | -0.5 | | 1.4 | -1.3 | -1.1 | -2.5 | -2.9 | 4.1 | 3.9 |
| | -0.5 | | 1.0 | -1.0 | 2.1 | 3.8 | -0.8 | 2.3 | 2.0 |
| -3.1 | -0.9 | -1.7 | 22.6 | -10.8 | 105.8 | 55.0 | -1.5 | 14.9 | 1.7 |
| -3.1 | -0.9 | -1.7 | 67.7 | -101.1 | 86.0 | 40.9 | -1.8 | 13.9 | 0.7 |
| -3.0 | -0.3 | -0.6 | 1.0 | -0.5 | 4.8 | 5.1 | -0.3 | 1.8 | 0.4 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
**BSE SME: 543516 | Symbol: DHYAANITR | ISIN: INE0K5F01014**
Dhyaani Tradeventtures Limited (formerly **Dhyaani Tile and Marblez Limited**) is an Indian listed entity currently undergoing a radical strategic transformation. Since **November 2023**, the company has pivoted from a specialized trader of vitrified tiles into a diversified conglomerate with interests spanning **Agro-commodities, Agri-tech, Artificial Intelligence (AI), and Real Estate Development**.
---
### **Strategic Pivot & Multi-Sectoral Expansion**
The company has systematically altered its **Memorandum of Association (MoA)** to transition from legacy building materials to high-growth, technology-driven sectors.
* **Agri-tech & Commodities (November 2023):** The primary revenue driver, focusing on trading staples and manufacturing modern agricultural implements.
* **Artificial Intelligence & IT Services (September 2023):** Development of **AI-based application solutions** for task automation, image processing, and process control software.
* **Real Estate & Infrastructure (July 2024):** New authorization to operate as **Contractors, Builders, and Town Planners**, covering land acquisition and civil works both in India and internationally.
* **Global Footprint:** Establishment of wholly-owned subsidiaries including **Dhyani Cyberrtech FZE / Dhyaani Connsultech FZE** (Dubai, UAE) and **Dhyani Cyberrnest Private Limited** (India), with planned expansions into the **USA**.
---
### **Core Business Verticals & Product Portfolio**
#### **1. Agricultural Commodities & Inputs**
This segment now accounts for over **95% of sales revenue**. The company utilizes a lean inventory model with a distribution network of **40+ traders**.
* **Rice Varieties:** Boil Rice, **Dubar Rice**, Jirasar Rice, **Parimal Rice**, and Sharbati Rice.
* **Pulses & Legumes:** Desi Chana, **Kabuli Chana**, Kashmiri Rajma, **Moong Dal**, Moong Mogar, **Tuver Dal**, Urad Dal, and **Urad Kali**.
* **Agri-Inputs:** Trading in fertilizers, micronutrients, pesticides, and insecticides.
* **Consumer Goods:** Trading in tobacco products (cigarettes, cigars), pan masala, and matchboxes.
#### **2. Building Materials (Legacy Operations)**
The company maintains its presence in high-strength flooring solutions:
* **Double Charge Vitrified Tiles:** Features a **3mm to 4mm thicker** pigment layer for heavy-traffic commercial use.
* **Glazed Vitrified Tiles:** Composed of clay, feldspar, and quartz with high-temperature firing for **low water absorption**.
#### **3. Life Sciences & R&D**
Through its subsidiary, **Astec LifeSciences Limited**, the company engages in:
* **Agrochemical Actives:** Technical manufacturing of core chemical components.
* **Innovation:** R&D focused on optimizing **process efficiencies** and enhancing **product yields**.
---
### **Operational Performance & Financial Growth**
The shift to agro-commodities has resulted in a massive scale-up of the top line.
| Metric | FY 2023-24 | FY 2022-23 | Change (%) |
| :--- | :--- | :--- | :--- |
| **Total Turnover** | **₹ 29.67 Crore** | **₹ 9.23 Crore** | **+221.4%** |
| **Net Profit / (Loss)** | **₹ 68.64 Lakhs** | **(₹ 7.71 Lakhs)** | **Turnaround** |
| **Total Equity** | **₹ 4.95 Crore** | **₹ 4.26 Crore** | **+16.2%** |
| **Total Debt** | **₹ 3.03 Crore** | **₹ 0.09 Crore** | **Significant Increase** |
*Note: For the period **FY 2024-25**, the company reported a turnover of **₹ 12.28 Crore** and a Net Profit of **₹ 24.81 Lakhs**.*
---
### **Capital Restructuring & Fundraising Strategy**
To fund its aggressive diversification, the company has significantly expanded its capital base and borrowing powers.
* **Authorized Share Capital:** Increased from **₹ 1.60 Cr** (Sep 2023) to **₹ 18.00 Cr** (Aug 2024), with a proposal to reach **₹ 24.55 Cr**.
* **Rights Issue (Sep 2024):** Successfully raised **₹ 29.37 Crore** by allotting **1,27,68,000 shares** at **₹ 23** per share.
* **Optionally Convertible Debentures (OCDs):**
* **Tranche I:** Approved **₹ 20 Crore** issue to **Quantum Quasar Capital** at **₹ 30.50** per OCD.
* **Tranche II:** A proposed **₹ 30 Crore** issue was **abstained** following an investor request in January 2025.
* **Borrowing Limits:** Shareholders approved an increase in borrowing powers up to **₹ 500 Crores** to meet long-term strategic objectives.
* **Bonus Issue:** Executed a **9:5 ratio** bonus issue in October 2023.
---
### **Operational Workflow & Efficiency Targets**
The company employs a structured quality-control workflow to mitigate risks in the fragmented commodity market:
1. **Dealer Selection:** Rigorous evaluation of financial stability and logistical reach.
2. **Quality Verification:** Sampling for purity, moisture, and nutrient levels.
3. **Logistics Optimization:** Direct delivery from godowns to customers to maintain **minimal inventory days**.
4. **Tech Integration:** Plans to implement **Blockchain, AI, and GIS** to achieve cost reductions and functional efficiencies.
---
### **Governance & Corporate Structure**
* **Leadership:** Led by Managing Director **Chintan Nayan Bhai Rajyaguru**. Recent board additions include **Amit Kapariya** (Executive Director) and **Reeta Devi** (Non-Executive Director).
* **Auditors:** **M/s S D P M & Co.** (Term ending **2028**).
* **Dividend Policy:** Currently **ploughing back all profits** into growth; no dividends recommended for FY 2025.
---
### **Critical Risk Factors & Compliance Challenges**
Investors should note several high-impact risks and regulatory hurdles:
* **Internal Control Lapses:** Auditors have flagged **inadequate internal financial controls** over financial reporting.
* **Regulatory Non-compliance:**
* Marked as **'SDD Non-Compliant'** by BSE regarding the Structured Digital Database.
* Faced fines for **delayed financial results** for FY 2024-25.
* Non-compliance with **e-way bill**, **e-invoice**, and **Section 206CR** (TCS) regulations.
* Outstanding **'Loan to Director'** as of March 2025, violating **Section 185** of the Companies Act.
* **Financial Risks:**
* **High Receivables:** Trade receivables stood at **₹ 30.42 Crores** (FY24), representing a significant portion of revenue.
* **Liquidity:** Unsecured loans of **₹ 3.03 Crore** are repayable on demand.
* **Operational Risks:**
* **Execution Risk:** Moving from tiles to AI and Real Estate involves steep learning curves.
* **Litigation:** A pending **NCLT** case involving a demand of **₹ 13.10 Crores** from Cengres Tiles Limited.
* **IP Risk:** Company **trademarks and logos are not registered**, leaving the brand vulnerable to infringement.
* **Concentration:** Operations are heavily concentrated in **Gujarat**, exposing the firm to regional economic shifts.